Johanna Holldack
Director/Board Member chez PHOTOCURE ASA
Fortune : - $ au 31/03/2024
Profil
Johanna Holldack is the founder and CEO of Kupando GmbH, which was founded in 2018.
She is currently the Chairman of Amal Therapeutics SA and an Independent Director at Photocure ASA since 2017.
Dr. Holldack's former positions include being the CEO of Borean Pharma ApS, Telormedix SA, and MediGene AG.
She was also a Partner at Aravis AG from 2009 to 2013, an Assistant Professor at the University of Duisburg-Essen, a Research Associate at Harvard Medical School, and a Member of Deutsche Krebshilfe gGmbH.
Dr. Holldack received her undergraduate and doctorate degrees from the University of Gottingen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHOTOCURE ASA
-.--% | 31/12/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Johanna Holldack
| Sociétés | Poste | Début |
|---|---|---|
| PHOTOCURE ASA | Director/Board Member | 28/04/2017 |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Chairman | - |
Kupando GmbH
 Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Chief Executive Officer | 29/03/2018 |
Anciens postes connus de Johanna Holldack
| Sociétés | Poste | Fin |
|---|---|---|
Aravis AG
 Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Private Equity Investor | 31/12/2013 |
Borean Pharma ApS
 Borean Pharma ApS Pharmaceuticals: MajorHealth Technology Borean Pharma ApS provides biopharmaceuticals drugs and protein engineering services. Its two main components of technology platform are CTLD library technology and trimerisation technology. The company was founded by Hans Christian Thøgersen and Michael Etzerodt in 1997 and is located in Aarhus, Denmark. | Chief Executive Officer | 16/04/2008 |
Deutsche Krebshilfe gGmbH
 Deutsche Krebshilfe gGmbH Miscellaneous Commercial ServicesCommercial Services Deutsche Krebshilfe gGmbH is a non-profit organization that fights against cancer by supporting various projects through donations. The non-profit company is based in Bonn, Germany and was founded in 1974 by Mildred Scheel. The German company provides information on funding projects, the origin and use of funds, and other relevant data in their annual report. The company encourages people to donate to their cause and provide answers to frequently asked questions about donations. The CEO is Gerd Nettekoven. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
| University of Duisburg-Essen | Corporate Officer/Principal | - |
Formation de Johanna Holldack
| University of Gottingen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| MEDIGENE AG | Health Technology |
| Entreprise privées | 6 |
|---|---|
Borean Pharma ApS
Borean Pharma ApS Pharmaceuticals: MajorHealth Technology Borean Pharma ApS provides biopharmaceuticals drugs and protein engineering services. Its two main components of technology platform are CTLD library technology and trimerisation technology. The company was founded by Hans Christian Thøgersen and Michael Etzerodt in 1997 and is located in Aarhus, Denmark. | Health Technology |
Aravis AG
Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Finance |
Telormedix SA
 Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland. | Health Technology |
Deutsche Krebshilfe gGmbH
Deutsche Krebshilfe gGmbH Miscellaneous Commercial ServicesCommercial Services Deutsche Krebshilfe gGmbH is a non-profit organization that fights against cancer by supporting various projects through donations. The non-profit company is based in Bonn, Germany and was founded in 1974 by Mildred Scheel. The German company provides information on funding projects, the origin and use of funds, and other relevant data in their annual report. The company encourages people to donate to their cause and provide answers to frequently asked questions about donations. The CEO is Gerd Nettekoven. | Commercial Services |
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Health Technology |
Kupando GmbH
Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Health Technology |
